GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sequana Medical NV (GREY:SQNMF) » Definitions » Total Inventories

Sequana Medical NV (Sequana Medical NV) Total Inventories : $3.01 Mil (As of Jun. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Sequana Medical NV Total Inventories?

Sequana Medical NV's total inventories for the quarter that ended in Jun. 2023 was $3.01 Mil. Sequana Medical NV's average total inventories from the quarter that ended in Dec. 2022 to the quarter that ended in Jun. 2023 was $2.89 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Sequana Medical NV's Net-Net Working Capital per share for the quarter that ended in Jun. 2023 was $-0.39.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Sequana Medical NV's Days Inventory for the three months ended in Jun. 2023 was 2,778.80.

Inventory Turnover measures how fast the company turns over its inventory within a year. Sequana Medical NV's Inventory Turnover for the quarter that ended in Jun. 2023 was 0.03.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Sequana Medical NV's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 6.95.


Sequana Medical NV Total Inventories Historical Data

The historical data trend for Sequana Medical NV's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequana Medical NV Total Inventories Chart

Sequana Medical NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Inventories
Get a 7-Day Free Trial Premium Member Only 1.41 1.78 1.79 2.42 2.78

Sequana Medical NV Quarterly Data
Dec15 Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.37 2.42 3.05 2.78 3.01

Sequana Medical NV Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Sequana Medical NV  (GREY:SQNMF) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Sequana Medical NV's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2023 is

Net-Net Working Capital Per Share (Q: Jun. 2023 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(18.55+0.75 * 0.121+0.5 * 3.01-31.134
-0-0)/28.1917
=-0.39

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Sequana Medical NV's Days Inventory for the three months ended in Jun. 2023 is calculated as:

Days Inventory=Average Total Inventories (Q: Jun. 2023 )/Cost of Goods Sold (Q: Jun. 2023 )*Days in Period
=2.893/0.095*365 / 4
=2,778.80

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Sequana Medical NV's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Jun. 2023 ) / Average Total Inventories (Q: Jun. 2023 )
=0.095 / 2.893
=0.03

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sequana Medical NV's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Jun. 2023 ) / Revenue (Q: Jun. 2023 )
=2.893 / 0.416
=6.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Sequana Medical NV Total Inventories Related Terms

Thank you for viewing the detailed overview of Sequana Medical NV's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Sequana Medical NV (Sequana Medical NV) Business Description

Comparable Companies
Traded in Other Exchanges
Address
Kortrijksesteenweg 1112 ,bus 102, Sint-Denijs-Westrem, Ghent, BEL, 9051
Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies and over 750 implants. The company's geographical segments include Switzerland, Germany, the United Kingdom, and the Rest of the world, out of which Germany accounts for the majority of the revenue.

Sequana Medical NV (Sequana Medical NV) Headlines

No Headlines